These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 25683958)

  • 1. Haemorrhagic thrombocytosis revisited?
    Lofaro T; Harrison CN
    Eur J Haematol; 2015 Jan; 94(1):1. PubMed ID: 25683958
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiplatelet therapy versus observation in low-risk essential thrombocythemia with a CALR mutation.
    Alvarez-Larrán A; Pereira A; Guglielmelli P; Hernández-Boluda JC; Arellano-Rodrigo E; Ferrer-Marín F; Samah A; Griesshammer M; Kerguelen A; Andreasson B; Burgaleta C; Schwarz J; García-Gutiérrez V; Ayala R; Barba P; Gómez-Casares MT; Paoli C; Drexler B; Zweegman S; McMullin MF; Samuelsson J; Harrison C; Cervantes F; Vannucchi AM; Besses C
    Haematologica; 2016 Aug; 101(8):926-31. PubMed ID: 27175028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombocytosis.
    Schafer AI
    JAMA; 2015 Sep; 314(11):1171-2. PubMed ID: 26372588
    [No Abstract]   [Full Text] [Related]  

  • 4. Uncontrolled thrombocytosis in polycythemia vera is a risk for thrombosis, regardless of JAK2(V617F) mutational status.
    Ohyashiki K; Akahane D; Gotoh A; Ito Y; Tauchi T; Miyazawa K; Kimura Y; Ohyashiki JH
    Leukemia; 2007 Dec; 21(12):2544-5. PubMed ID: 17611562
    [No Abstract]   [Full Text] [Related]  

  • 5. [Vascular complications of essential thrombocythemia].
    Bellucci S
    Bull Acad Natl Med; 2007 Mar; 191(3):519-30; discussion 530-3. PubMed ID: 18072651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenomegaly and thrombosis risk in essential thrombocythemia: the Mayo Clinic experience.
    Haider M; Gangat N; Hanson C; Tefferi A
    Am J Hematol; 2016 May; 91(5):E296-7. PubMed ID: 26875150
    [No Abstract]   [Full Text] [Related]  

  • 7. Mutation of the prothrombin gene and thrombotic events in patients with polycythemia vera or essential thrombocythemia: a cohort study.
    Gisslinger H; Müllner M; Pabinger I; Heis-Vahidi-Fard N; Gisslinger B; Brichta A; Bachleitner-Hofmann T; Mannhalter C
    Haematologica; 2005 Mar; 90(3):408-10. PubMed ID: 15749677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review: challenges in the management of thrombocytosis in young patients.
    Robinson S; Harrison C
    Clin Adv Hematol Oncol; 2008 Feb; 6(2):137-8, 141. PubMed ID: 18347565
    [No Abstract]   [Full Text] [Related]  

  • 9. The impact of JAK2V617F mutation on different types of thrombosis risk in patients with essential thrombocythemia: a meta-analysis.
    Qin Y; Wang X; Zhao C; Wang C; Yang Y
    Int J Hematol; 2015 Aug; 102(2):170-80. PubMed ID: 25997869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of recurrent thrombosis in patients with essential thrombocythemia carrying the homozygous JAK2 V617F mutation.
    De Stefano V; Za T; Rossi E; Vannucchi AM; Ruggeri M; Elli E; Micò C; Tieghi A; Cacciola RR; Santoro C; Vianelli N; Guglielmelli P; Pieri L; Scognamiglio F; Cacciola E; Rodeghiero F; Pogliani EM; Finazzi G; Gugliotta L; Leone G; Barbui T;
    Ann Hematol; 2010 Feb; 89(2):141-6. PubMed ID: 19582452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history.
    Gangat N; Wassie EA; Lasho TL; Finke C; Ketterling RP; Hanson CA; Pardanani A; Wolanskyj AP; Maffioli M; Casalone R; Passamonti F; Tefferi A
    Eur J Haematol; 2015 Jan; 94(1):31-6. PubMed ID: 24889737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Too many platelets: the potential for bleeding.
    Harbrecht PJ
    Ann Surg; 1968 Mar; 167(3):399-402. PubMed ID: 5689023
    [No Abstract]   [Full Text] [Related]  

  • 13. Acute myocardial infarction: an unusual presentation of essential thrombocytosis in a 17-year-old man.
    Kelly SV; Burke RF; Lee KS; Torloni AS; Lee RW; Northfelt D; Fonseca R
    Clin Adv Hematol Oncol; 2008 Feb; 6(2):133-6. PubMed ID: 18347564
    [No Abstract]   [Full Text] [Related]  

  • 14. Thrombin generation and procoagulant phospholipids in patients with essential thrombocythemia and reactive thrombocytosis.
    Mignon I; Grand F; Boyer F; Hunault-Berger M; Hamel JF; Macchi L
    Am J Hematol; 2013 Dec; 88(12):1007-11. PubMed ID: 23873831
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebral Venous Sinus Thrombosis as the First Manifestation of JAK2
    Chen WB; Wang XL
    Chin Med J (Engl); 2018 Mar; 131(6):748-750. PubMed ID: 29521303
    [No Abstract]   [Full Text] [Related]  

  • 16. Transformed essential thrombocytosis with a JAK2 V617F mutation relapsing as JAK2 mutation-negative leukaemia after allogeneic stem cell transplantation.
    Au WY; Fung A; Lam KY; Lie AK; Liang R; Kwong YL
    Bone Marrow Transplant; 2006 Oct; 38(8):573-4. PubMed ID: 16953212
    [No Abstract]   [Full Text] [Related]  

  • 17. No DNA sequence copy number changes in essential thrombocythemia.
    Larramendy ML; Knuutila S; Jantunen R; Ruutu T; Juvonen E
    Cancer Genet Cytogenet; 2001 Sep; 129(2):181-2. PubMed ID: 11572227
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship between factor V Leiden, prothrombin G20210A, and MTHFR mutations and the first major thrombotic episode in polycythemia vera and essential thrombocythemia.
    Trifa AP; Cucuianu A; Popp RA; Coadă CA; Costache RM; Militaru MS; Vesa ŞC; Pop IV
    Ann Hematol; 2014 Feb; 93(2):203-9. PubMed ID: 23828072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. JAK2 mutation-negative essential thrombocythemia in a child presenting with cerebral venous thrombosis.
    Khan AA; Kumar V; Anand I; Kumar M; Sharma P; Bhargava M
    Hematol Oncol Stem Cell Ther; 2012; 5(1):66-8. PubMed ID: 22446615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A Case of Essential Thrombocythemia with a JAK2V617F Mutation andPolymyalgia Rheumatica].
    Shinohara K
    Gan To Kagaku Ryoho; 2018 Jun; 45(6):1001-1003. PubMed ID: 30026432
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.